Cargando…
Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121445/ https://www.ncbi.nlm.nih.gov/pubmed/33175968 http://dx.doi.org/10.1093/rheumatology/keaa623 |
_version_ | 1783692354980413440 |
---|---|
author | Paalanen, Kirsi Puolakka, Kari Nikiphorou, Elena Hannonen, Pekka Sokka, Tuulikki |
author_facet | Paalanen, Kirsi Puolakka, Kari Nikiphorou, Elena Hannonen, Pekka Sokka, Tuulikki |
author_sort | Paalanen, Kirsi |
collection | PubMed |
description | OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients who were diagnosed with incident seronegative RA [International Classification of Diseases (ICD)-10 code M06] from 1 January 2000 to 31 December 2014. The patients whose diagnoses subsequently changed to the ICD-10 codes of SpA (M07, M45, M46, K50 and K51) were identified in the national care register, until 31 December 2016. RESULTS: A total of 9784 adult seronegative RA patients were identified. Of these, 564 patients had their diagnosis subsequently changed to SpA: 275 (48.7%) patients with PsA, 245 (43.4%) patients with axial SpA and 44 (7.8%) patients with diagnoses related to IBD. The cumulative incidence of SpA diagnoses in 15 years was 10.4% (95% CI 8.9, 12.1) and 8.1% (95% CI 7.1, 9.3) in men and women, respectively. CONCLUSION: This study calls for vigilance in seronegative RA patients, especially those with more atypical presentations, since the diagnosis could change. The possibility of SpA diagnosis should be considered and specifically looked for, as this could impact on management and response to treatment. |
format | Online Article Text |
id | pubmed-8121445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-81214452021-05-19 Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study Paalanen, Kirsi Puolakka, Kari Nikiphorou, Elena Hannonen, Pekka Sokka, Tuulikki Rheumatology (Oxford) Clinical Science OBJECTIVES: The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. METHODS: Using nationwide Finnish registers from social insurance institutions, we identified all adult patients who were diagnosed with incident seronegative RA [International Classification of Diseases (ICD)-10 code M06] from 1 January 2000 to 31 December 2014. The patients whose diagnoses subsequently changed to the ICD-10 codes of SpA (M07, M45, M46, K50 and K51) were identified in the national care register, until 31 December 2016. RESULTS: A total of 9784 adult seronegative RA patients were identified. Of these, 564 patients had their diagnosis subsequently changed to SpA: 275 (48.7%) patients with PsA, 245 (43.4%) patients with axial SpA and 44 (7.8%) patients with diagnoses related to IBD. The cumulative incidence of SpA diagnoses in 15 years was 10.4% (95% CI 8.9, 12.1) and 8.1% (95% CI 7.1, 9.3) in men and women, respectively. CONCLUSION: This study calls for vigilance in seronegative RA patients, especially those with more atypical presentations, since the diagnosis could change. The possibility of SpA diagnosis should be considered and specifically looked for, as this could impact on management and response to treatment. Oxford University Press 2020-11-11 /pmc/articles/PMC8121445/ /pubmed/33175968 http://dx.doi.org/10.1093/rheumatology/keaa623 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Science Paalanen, Kirsi Puolakka, Kari Nikiphorou, Elena Hannonen, Pekka Sokka, Tuulikki Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title | Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title_full | Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title_fullStr | Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title_full_unstemmed | Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title_short | Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study |
title_sort | is seronegative rheumatoid arthritis true rheumatoid arthritis? a nationwide cohort study |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121445/ https://www.ncbi.nlm.nih.gov/pubmed/33175968 http://dx.doi.org/10.1093/rheumatology/keaa623 |
work_keys_str_mv | AT paalanenkirsi isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy AT puolakkakari isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy AT nikiphorouelena isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy AT hannonenpekka isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy AT sokkatuulikki isseronegativerheumatoidarthritistruerheumatoidarthritisanationwidecohortstudy |